secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartBeam, Inc. (BEAT)
CIK:        0001779372
Form:       8-K
Filed at:   2023-07-26T23:59:59+00:00
Accession:  0001779372-23-000019
Event type: leadership
Sentiment:  positive
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HeartBeam appoints Dr. Michael R. Jaff to board effective July 24, 2023
-----------------------------------------------------------------------

- Board size increased to 8 directors to accommodate appointment of Dr. Jaff.
- Dr. Jaff is CMO and VP at Boston Scientific; former Harvard professor and hospital president.
- He is founder of VasCore and Past-President of the Society for Vascular Medicine.
- No family relationships or related party transactions reported with the new director.
- Press release announcing appointment issued on July 26, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779372/000177937223000019/0001779372-23-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779372/000177937223000019/beat-20230724.htm
  HTML page:      https://secwatch.observer/filing/0001779372-23-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer